![Matthew Angel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Angel
Vorstandsvorsitzender bei
TEMPEST THERAPEUTICS, INC.
Vermögen: 8 Mio $ am 31.05.2026
Profil
Matthew Angel was the founder of Novellus LLC, founded in 2014, serving as Chief Science Officer from 2014 to 2021.
Dr. Angel is the founder of Exacis Biotherapeutics, Inc., founded in 2020, serving as Director & Chief Scientific Officer since 2020.
Dr. Angel is the founder of Factor Bioscience, Inc., founded in 2011, serving as Chairman & Chief Executive Officer since 2024.
Dr. Angel is currently President, Chief Executive Officer & Director at Tempest Therapeutics, Inc. since 2026.
Formerly, Dr. Angel was President & Chief Executive Officer at Ernexa Therapeutics, Inc. in 2023.
Education includes a doctorate from Massachusetts Institute of Technology and an undergraduate degree from Princeton University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TEMPEST THERAPEUTICS, INC. 41,03 % | 24.03.2026 | 5.531.516 ( 41,03 % ) | 8 Mio $ | 31.05.2026 |
Aktive Positionen von Matthew Angel
| Unternehmen | Position | Beginn |
|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Vorstandsvorsitzender | 03.02.2026 |
Factor Bioscience, Inc.
 Factor Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Develops regenerative medicine by targeting and repairing the molecular origins of disease | Vorstandsvorsitzender | 01.01.2011 |
Exacis Biotherapeutics, Inc.
 Exacis Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Gründer | 01.01.2020 |
Ehemalige bekannte Positionen von Matthew Angel
| Unternehmen | Position | Ende |
|---|---|---|
| ERNEXA THERAPEUTICS INC. | Vorstandsvorsitzender | 31.12.2023 |
| ERNEXA THERAPEUTICS INC. | Vorstandsvorsitzender | 04.08.2023 |
Novellus LLC
 Novellus LLC Pharmaceuticals: MajorHealth Technology Operates a pre-clinical stage biotechnology company that develops engineered cellular medicines | Gründer | 01.07.2021 |
Ausbildung von Matthew Angel
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novellus LLC
Novellus LLC Pharmaceuticals: MajorHealth Technology Operates a pre-clinical stage biotechnology company that develops engineered cellular medicines | Health Technology |
Factor Bioscience, Inc.
Factor Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Develops regenerative medicine by targeting and repairing the molecular origins of disease | Commercial Services |
Exacis Biotherapeutics, Inc.
Exacis Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
Eterna Therapeutics, Inc.
 Eterna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Health Technology |
Tempest Therapeutics, Inc.
 Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
